Atlas Trials

MK0524A Bioequivalence Study (0524A-059)

Clinical trial NCT00944645 · COMPLETED

Trial details

NCT number
NCT00944645
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Dyslipidemia
Start date
2006-10-01
Primary completion
2007-01-01
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.